It strikes me as bizarre that pharmaceutical companies are still pursuing a drug to treat a "disorder"—low sexual desire in women—that appears manufactured, in my opinion, by the companies trying to treat it. In this week's New England Journal of Medicine, researchers triumphantly tout a testosterone patch, saying that it appears to increase the number of satisfying sexual encounters that women have.
The trade-off for slightly better sex? Unwanted hair growth in manly places like the face and chest. And the possibility of increased breast cancer. Four cases of breast cancer were diagnosed in the study, which involved 800 postmenopausal women; none of the four were on the placebo patch. While the researchers say these "may be due to chance," they add that "the possibility of a causal relationship must be considered."
Read more....
No comments:
Post a Comment